Literature DB >> 26984434

Congenital cytomegalovirus infection: contribution and best timing of prenatal MR imaging.

Mieke M Cannie1,2, Roland Devlieger3, Mina Leyder4, Filip Claus5,6, Astrid Leus2, Luc De Catte3, Veerle Cossey7, Ina Foulon8, Elise Van der Valk3, Walter Foulon4, Teresa Cos9, Anja Bernaert10, Raymond Oyen5, Jacques C Jani11.   

Abstract

OBJECTIVE: To predict sensorineural hearing loss (SNHL) and neurological impairment in congenital cytomegalovirus (cCMV) infection using MR imaging and define the best timing in pregnancy for prenatal assessment.
METHODS: In 121 patients with confirmed cCMV infection, brain features at MR imaging were respectively graded from 1 to 5: normal; isolated frontal/parieto-occipital hyperintensity; temporal periventricular hyperintensity; temporal/occipital cysts and/or intraventricular septa; migration disorders. Grading was correlated with postnatal SNHL and neurological impairment using regression analysis. In 51 fetuses with MR examinations at 26.9 and 33.0 weeks, the predictive value of SNHL and neurological impairment was compared using ROC curves.
RESULTS: Postnatal follow-up showed SNHL in 18 infants and neurological impairment in 10. MR grading was predictive of SNHL and of neurological impairment (P < 0.001). In grade 1 or 2, none had SNHL and 1/74 had neurological impairment. The areas under ROC curves for prediction of postnatal SNHL and of neurological impairment from first and second MR examination were comparable.
CONCLUSION: Our data suggest that in cCMV infection, prediction of SNHL and neurological impairment is feasible by fetal MR imaging with a high negative predictive value and can equally be done at 27 or 33 weeks of gestation. KEY POINTS: • In cCMV, isolated periventricular T2-weighted signal hyperintensity has a good postnatal prognosis. • In cCMV, SNHL and neurological impairment can be predicted at 27 or 33 weeks. • In cCMV, fetal MR has a high NPV in predicting SNHL. • In cCMV, fetal MR has a high NPV in predicting neurological impairment.

Entities:  

Keywords:  Congenital CMV; Fetal MRI; Fetal infection; Polar temporal lesions; Sensorineural hearing loss

Mesh:

Year:  2016        PMID: 26984434     DOI: 10.1007/s00330-015-4187-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection.

Authors:  S Lipitz; C Hoffmann; B Feldman; M Tepperberg-Dikawa; E Schiff; B Weisz
Journal:  Ultrasound Obstet Gynecol       Date:  2010-04-15       Impact factor: 7.299

2.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

3.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

4.  Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age.

Authors:  Gisela Enders; Anja Daiminger; Ursula Bäder; Simone Exler; Martin Enders
Journal:  J Clin Virol       Date:  2011-08-05       Impact factor: 3.168

5.  Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging.

Authors:  G Benoist; L J Salomon; M Mohlo; B Suarez; F Jacquemard; Y Ville
Journal:  Ultrasound Obstet Gynecol       Date:  2008-12       Impact factor: 7.299

6.  Language of early- and later-identified children with hearing loss.

Authors:  C Yoshinaga-Itano; A L Sedey; D K Coulter; A L Mehl
Journal:  Pediatrics       Date:  1998-11       Impact factor: 7.124

7.  Prenatal cytomegalovirus disease and cerebral microgyria: evidence for perfusion failure, not disturbance of histogenesis, as the major cause of fetal cytomegalovirus encephalopathy.

Authors:  M J Marques Dias; G Harmant-van Rijckevorsel; P Landrieu; G Lyon
Journal:  Neuropediatrics       Date:  1984-02       Impact factor: 1.947

8.  A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection.

Authors:  Ina Foulon; Anne Naessens; Walter Foulon; Ann Casteels; Frans Gordts
Journal:  J Pediatr       Date:  2008-03-06       Impact factor: 4.406

9.  Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection.

Authors:  Olivier Picone; Isabelle Simon; Alexandra Benachi; Francis Brunelle; Pascale Sonigo
Journal:  Prenat Diagn       Date:  2008-08       Impact factor: 3.050

Review 10.  Cytomegalovirus in pregnancy: to screen or not to screen.

Authors:  Susan P Walker; Ricardo Palma-Dias; Erica M Wood; Paul Shekleton; Michelle L Giles
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-18       Impact factor: 3.007

View more
  11 in total

Review 1.  Testing for Cytomegalovirus in Pregnancy.

Authors:  Alda Saldan; Gabriella Forner; Carlo Mengoli; Nadia Gussetti; Giorgio Palù; Davide Abate
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  Quantitative and qualitative analysis of fetal temporal lobe T2 signal in cytomegalovirus infected fetuses and normal controls.

Authors:  Larisa Gorenstein; Eldad Katorza; Omer Bar-Yosef; Chen Hoffmann; Shai Shrot
Journal:  Quant Imaging Med Surg       Date:  2021-10

3.  MRI findings in children with congenital cytomegalovirus infection retrospectively diagnosed with dried umbilical cord.

Authors:  Hiroyuki Kidokoro; Anna Shiraki; Yuka Torii; Masaharu Tanaka; Hiroyuki Yamamoto; Hirokazu Kurahashi; Koichi Maruyama; Akihisa Okumura; Jun Natsume; Yoshinori Ito
Journal:  Neuroradiology       Date:  2020-11-17       Impact factor: 2.804

4.  Symptomatic Congenital Cytomegalovirus Infection in Children of Seropositive Women.

Authors:  Ines Mack; Marie-Anne Burckhardt; Ulrich Heininger; Friederike Prüfer; Sven Schulzke; Sven Wellmann
Journal:  Front Pediatr       Date:  2017-06-09       Impact factor: 3.418

5.  The MRI spectrum of congenital cytomegalovirus infection.

Authors:  Mariana C Diogo; Sarah Glatter; Julia Binder; Herbert Kiss; Daniela Prayer
Journal:  Prenat Diagn       Date:  2020-01-06       Impact factor: 3.050

6.  A congenital CMV infection model for follow-up studies of neurodevelopmental disorders, neuroimaging abnormalities, and treatment.

Authors:  Yue-Peng Zhou; Meng-Jie Mei; Xian-Zhang Wang; Sheng-Nan Huang; Lin Chen; Ming Zhang; Xin-Yan Li; Hai-Bin Qin; Xiao Dong; Shuang Cheng; Le Wen; Bo Yang; Xue-Fang An; Ao-Di He; Bing Zhang; Wen-Bo Zeng; Xiao-Jun Li; Youming Lu; Hong-Chuang Li; Haidong Li; Wei-Guo Zou; Alec J Redwood; Simon Rayner; Han Cheng; Michael A McVoy; Qiyi Tang; William J Britt; Xin Zhou; Xuan Jiang; Min-Hua Luo
Journal:  JCI Insight       Date:  2022-01-11

Review 7.  Congenital Cytomegalovirus and Human Immunodeficiency Virus: Effects on Hearing, Speech and Language Development, and Clinical Outcomes in Children.

Authors:  Hannah Walsh; Jillian Zuwala; Jessica Hunter; Yonghee Oh
Journal:  Front Pediatr       Date:  2021-12-16       Impact factor: 3.418

8.  Current practices of management of maternal and congenital Cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: Systematic review.

Authors:  Claire Périllaud-Dubois; Drifa Belhadi; Cédric Laouénan; Laurent Mandelbrot; Olivier Picone; Christelle Vauloup-Fellous
Journal:  PLoS One       Date:  2021-12-03       Impact factor: 3.240

Review 9.  Imaging of congenital central nervous system infections.

Authors:  Ilana Neuberger; Jacquelyn Garcia; Mariana L Meyers; Tamara Feygin; Dorothy I Bulas; David M Mirsky
Journal:  Pediatr Radiol       Date:  2018-03-17

10.  Prediction of the Outcome of Cochlear Implantation in the Patients with Congenital Cytomegalovirus Infection based on Magnetic Resonance Imaging Characteristics.

Authors:  Jae Joon Han; Yun Jung Bae; Seul Ki Song; Jae-Jin Song; Ja-Won Koo; Jun Ho Lee; Seung Ha Oh; Bong Jik Kim; Byung Yoon Choi
Journal:  J Clin Med       Date:  2019-01-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.